相关实验视频

Updated: May 20, 2025

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

Published on: February 28, 2020

在黑色素瘤可塑性中,MITF和TFE3的对抗作用

Jeremy Chang¹, Katelyn R Campbell-Hanson¹, Marion Vanneste²

¹Department of Surgery, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.

|March 26, 2025

概括

黑色素瘤细胞切换状态,推动癌症的进展. 研究人员发现,TFE3蛋白促进侵袭,而MITF蛋白通过激活降解TFE3的途径来抑制它,控制黑色素瘤的可塑性.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
细胞生物学细胞生物学

背景情况:

黑色素瘤表现出可塑性,在黑色素细胞/增殖和中细胞/侵入性状态之间切换.
这种可塑性有助于瘤异质性,进展和对治疗的抵抗.
众所周知,微相关转录因子 (MITF) 促进黑色细胞表型,但介质细胞状态的调节者尚不清楚.

研究的目的:

为了确定黑色素瘤中介质细胞表型的调节者.
阐明控制黑色素瘤细胞状态可塑性的机制.
调查TFE3和非正规的mTORC1通路在黑色素瘤侵入性中的作用.

主要方法:

研究了TFE3作为一个调节间酶体状态的MITF对应物.
评估了TFE3表达对黑色素瘤细胞迁移和转移的影响.
研究了MITF在调节非正规mTORC1通路 (FNIP1,FNIP2,FLCN) 的组件中的作用.
通过 lysosomal 途径研究了 TFE3 的降解.

主要成果:

确定TFE3表达是黑色素瘤转移性表型的驱动因素.
删除TFE3显著减少了MITF低的黑色素瘤细胞的迁移和转移.
通过激活FNIP1,FNIP2和FLCN,MITF被证明可以通过激活FNIP1,FNIP2和FLCN来抑制中细胞表型.
这些因素促进了TFE3在细胞质中的保留及其降解.

结论:

TFE3和非正规的mTORC1通路是黑色素瘤细胞可塑性和侵入性的关键调节者.
通过激活FNIP1/FNIP2/FLCN复合体,MITF抑制了间酶体表型,导致TFE3降解.
这一途径为控制黑色素瘤进展和转移提供了潜在的治疗点.

关键词:

CP: 癌症癌症癌症科普:基因组学基因组学美国MITF MITF TFE3 TFE3 的时间.细胞的可塑性细胞的可塑性在 mTORC1 的情况下,mTORC1 是黑色素瘤是一种黑色素瘤.转移转移转移转移现象型切换转换现象型切换蛋白质的稳定性蛋白质的稳定性

更多相关视频

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Master Transcription Regulators

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.